Applied Genetic Technologies Corporation announced the appointments of Lanita C. Scott, M.D., to the position of Vice President of Clinical Research and Medical Affairs and Karen M. Carroll, RN, to the position of Vice President of Clinical Development Operations. Dr. Scott brings more than 20 years of experience in medical affairs to her new role, with a proven track record in strategic research, product positioning, publication planning, key opinion leader development and clinical trial design. She also led her own ophthalmology/glaucoma private practice for several years. Prior to joining AGTC, Dr. Scott served as Head, Global Strategic Research, Senior Medical Director, and Global Medical Affairs for Santen Inc. Ms. Carroll is a registered nurse and experienced clinical operations professional, with extensive experience in rare disease drug development. Most recently, she served as Vice President of Clinical Operations at Promedior, where she contributed to the successful business development deal with Bristol Myers Squibb, completed enrollment of a global Phase 2 clinical trial ahead of schedule and lead the global team to successful data read out.